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Introduction
Ca
2+ signals are involved in many cell processes from early cell 
differentiation to cell death. They are encoded in frequency,   
amplitude, duration, and localization of cytosolic Ca
2+ transient 
increases (Berridge et al., 2003). Two Ca
2+ sources enable these 
signals:  influxes  from  extracellular  fluids  and  releases  from   
internal stores. These two sources are interdependent, as the Ca
2+ 
content of the stores is regulated by an influx from the extra­
cellular environment by a process termed store­operated Ca
2+ 
entry (SOCE).
Cellular events connecting Ca
2+ store depletion to SOCE 
activation have been clarified recently with the identification of 
two major SOCE components: the stromal interaction mole­
cules (STIMs) STIM1 and STIM2 and the Orai family of chan­
nels Orai1–3. STIMs are single­pass transmembrane ER Ca
2+ 
sensors that activate SOCE upon Ca
2+ store depletion (Liou   
et al., 2005; Roos et al., 2005; Brandman et al., 2007; Wang   
et al., 2009; Zhou et al., 2009). When Ca
2+ decreases in the 
stores, STIMs slowly redistribute into clusters where they co­
localize with Orai channels to form elementary subunits of SOCE 
(Liou et al., 2005; Luik et al., 2006; Mercer et al., 2006; Treves 
et al., 2010). Recent publications describe specific sequences of 
STIMs involved in oligomerization, cluster formation, and Orai 
activation (Liou et al., 2005; Baba et al., 2006; Zeng et al., 2008; 
Fahrner et al., 2009; Muik et al., 2009; Park et al., 2009; Yuan   
et al., 2009).
In mammalian skeletal muscle cells, single­twitch con­
tractions are controlled by ER Ca
2+ releases without noticeable 
contribution of Ca
2+ influxes (Lamb, 2000; Launikonis et al., 
2010). However, during repetitive twitches, SOCE is required, 
thus providing an excellent model for studying Ca
2+ store   
regulation during repetitive Ca
2+ releases (Stiber et al., 2008;   
Darbellay et al., 2010). Accordingly, STIM1­deficient human 
patients and mice present an abnormal muscular fatigability 
(Stiber et al., 2008; Feske, 2009, 2010; Picard et al., 2009; Feske 
et al., 2010). STIM1 has been shown to be permanently local­
ized within the triad junction of muscle fibers (Stiber et al., 
2008). This may be part of the reason for the fast SOCE activa­
tion in muscle (<1 s) when compared with that of other cell 
types (30 s to >1 min; Parekh and Putney, 2005; Wu et al., 2006; 
Launikonis and Ríos, 2007; Liou et al., 2007; Navarro­Borelly 
et  al.,  2008;  Stiber  et  al.,  2008;  Calloway  et  al.,  2009;   
C
ytosolic Ca
2+ signals encoded by repetitive Ca
2+ 
releases rely on two processes to refill Ca
2+ stores: 
Ca
2+ reuptake from the cytosol and activation of   
a Ca
2+ influx via store-operated Ca
2+ entry (SOCE). How-
ever, SOCE activation is a slow process. It is delayed by   
>30 s after store depletion because stromal interaction   
molecule 1 (STIM1), the Ca
2+ sensor of the intracellular 
stores, must form clusters and migrate to the membrane 
before being able to open Orai1, the plasma membrane 
Ca
2+ channel. In this paper, we identify a new protein, 
STIM1L, that colocalizes with Orai1 Ca
2+ channels and 
interacts with actin to form permanent clusters. This prop-
erty allowed the immediate activation of SOCE, a charac-
teristic required for generating repetitive Ca
2+ signals with 
frequencies within seconds such as those frequently ob-
served in excitable cells. STIM1L was expressed in several 
mammalian tissues, suggesting that many cell types rely 
on this Ca
2+ sensor for their Ca
2+ homeostasis and intra-
cellular signaling.
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a new 115­kD STIM1 named STIM1L (Fig. 1 A). STIM1L was 
detected in all tested skeletal muscles (gluteus, vastus lateralis, 
gastrocnemius, diaphragm, and tongue) and in the three tissues 
belonging to the central nervous system (brain, cerebellum, and 
brain stem). STIM1L was also detected in the spleen, lungs, 
liver, and heart but not in the kidney. Note that, as previously 
described (Berna­Erro et al., 2009), STIM1S is ubiquitously ex­
pressed in mouse tissues. Because STIM1L is highly expressed 
in all skeletal muscles (and not in T lymphocytes; Fig. 1 A), we 
decided to use cultured multinucleated myotubes to decipher its 
molecular and functional characteristics.
We  first  confirmed  that  STIM1L  is  expressed  in  adult   
human muscle fibers and in in vitro–differentiated myotubes. The 
time course of STIM1 expression during the first 52 h of myotube 
differentiation is illustrated in Fig. 1 B. STIM1L appeared during 
the second day of differentiation and is abundantly expressed in 
adult human semitendinous muscle. The two 90­ and 115­kD 
proteins were recognized by three different anti­STIM1 anti­
bodies  and  were  both  silenced  by  different  siRNAs  directed 
against STIM1 (small interfering STIM1 [siSTIM1]; Figs. 1 C 
[left] and S1 A). Western blot quantification showed that siSTIM1 
reduced the expression of the 90­kD protein by 88 ± 6% and that 
of the 115­kD protein by 90 ± 10% (n = 3, and P < 10
6 for both 
conditions; Fig. 1 B, right). Collectively, these results identify 
STIM1L as a new member of the STIM1 protein family.
STIM1L results from an alternative splicing 
on exon 11
We performed an RNA ligase–mediated rapid amplification of 
5 and 3 cDNA ends (RACE) followed by PCR amplification 
Dirksen, 2009; Launikonis et al., 2009; Edwards et al., 2010). 
However, the molecular mechanisms underlying this fast SOCE 
activation are not completely understood.
In this study, we cloned a new splice variant of STIM1, 
STIM1L (L for long; the already well­described 90­kD STIM1 
molecule will be called STIM1S in this paper), and character­
ized its role in cytosolic Ca
2+ homeostasis. STIM1L triggers   
immediate SOCE activation upon Ca
2+ store release and forms 
permanent clusters that colocalize with Orai1. These permanent 
clusters are independent of the Ca
2+ content of stores and rely on 
an interaction between STIM1L and actin fibers. As both STIM1 
variants (STIM1S and STIM1L) are strongly expressed in mam­
malian skeletal muscle cells, we decided to mainly use human 
myotubes produced by in vitro differentiation to analyze the   
endogenous function of STIM1L. We show that in myotubes   
silenced for endogenous STIM1L, SOCE activation was delayed, 
and repetitive depolarization­induced Ca
2+ releases were pre­
cluded as they rapidly emptied Ca
2+ stores. On the other hand, 
overexpression of STIM1L in cells that do not endogenously 
express this protein drastically accelerated SOCE activation. We 
conclude that Ca
2+ signals encoded by fast repetitive releases   
require the immediate activation of SOCE triggered by STIM1L.
Results
Two distinct STIM1 proteins are expressed 
in various mammalian tissues
Two STIM1 proteins of different size are expressed in most mu­
rine tissues: the well­known 90­kD STIM1 (from now on, we 
will refer to this protein as STIM1S, with S denoting small) and 
Figure  1.  Identification  of  a  new  widely 
expressed STIM1 isoform. (A) Expression of 
STIM1  splice  variants  (N-terminal  antibody) 
in adult mouse tissues and in T lymphocytes 
of two different patients. -Tubulin (-tub) was 
used for a loading control. (B) STIM1 expres-
sion  during  myoblast  differentiation  and  in 
adult human skeletal muscle (N-terminal anti-
body). (C, left) STIM1 expression (N-terminal 
antibody) 96 h after transfection with a con-
trol  siRNA  (control)  or  with  an  siRNA  that   
silenced  both  STIM1  isoforms  (siSTIM1).   
(right)  Quantification  of  STIM1  silencing  effi-
ciency (mean ± SD). STIM1 expression was 
normalized to control STIM1S levels and cor-
rected for loading differences using -tubulin 
(also see Fig. S1 A).337 Fast repetitive Ca
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STIM1L­overexpressing  myoblasts  deprived  of  endogenous 
STIM1S  and  treated  with  an  siRNA  directed  against  Orai1 
(siOrai1). Fig. 3 C shows that most of the gain of function con­
ferred by the overexpression of STIM1L in STIM1S­silenced 
myoblasts was reversed by Orai1 silencing (compare blue and 
cyan curves). This result identifies Orai1 as the main partner 
of STIM1L. However, as the residual SOCE in Orai1­silenced 
myoblasts  overexpressing  STIM1L  (cyan  curve)  is  approxi­
mately sevenfold larger than that observed in Orai1­silenced 
myoblasts not overexpressing STIM1L (green curve), our re­
sults do not exclude that STIM1L may also activate Ca
2+ 
channels other than Orai1. The Western blot in Fig. 3 D  
illustrates Orai1 silencing efficiency. A 65 ± 5% decrease of 
Orai1 expression was observed in myoblasts transfected with 
siOrai1 (n = 3).
To assess the endogenous function of STIM1L, we used 
differentiated skeletal muscle cells (myotubes), as these cells 
strongly express both STIM1 variants (Fig. 1 A). To silence 
STIM1L, we designed three siRNAs that targeted sequences 
specific to the new spliced fragment of exon 11. As shown in 
Fig. 3 E, the three siRNAs efficiently silenced STIM1L (90 ± 6, 
91 ± 7, and 91 ± 5% inhibition for siSTIM1L­1, ­2, and ­3, 
respectively) without significantly affecting STIM1S. Fig. 3 F  
illustrates that Tg­induced SOCE amplitude was reduced by   
56 ± 9% in STIM1L­silenced myotubes (n = 4 and P < 0.003; 
siSTIM1L­1 was used in this and all following experiments).
using STIM1­specific primers (see Materials and methods) to 
evaluate any possible alternative splicing on STIM1 mRNA. 
Only one band of the expected size (1.5 kb) was revealed by   
5 end amplification of mRNA from differentiating myotubes 
(Fig. S1 B, left). On the other hand, 3 end amplification identi­
fied one band in mRNA from myoblasts but two bands in myo­
tubes (Figs. 2 A and S1 B). Sequencing of both bands confirmed 
the specific amplification of STIM1 cDNA and identified a new 
sequence inserted between exons 11 and 12 of the known stim1 
human gene (available from GenBank/EMBL/DDBJ under ac­
cession no. NG_016277). This 318­bp segment aligned in silico 
with a sequence immediately after exon 11 in the stim1 human 
gene. From these results, we conclude that during human myo­
blast differentiation, an alternative splicing occurs on exon 11 
of STIM1, producing a new STIM1 protein characterized by a 
longer exon 11 encoding a longer cytosolic C­terminal tail (Fig. 2, 
B and C). Fig. 2 D shows the amino acid sequence of the addi­
tional segment displaying threonine­ and serine­rich domains 
(the nucleotide sequence is shown in Fig. S1 C; available from 
GenBank  under  accession  no.  HQ317451). The  sequence  is 
highly conserved in mammalians, suggesting that it is involved 
in essential functions (Fig. S2 A). Additionally, we confirmed 
these findings by performing PCR using primers targeting   
exons 10 and 12 of STIM1 (Fig. S2 B).
STIM1L activates Orai1 upon  
store depletion and is involved in 
endogenous SOCE
To  evaluate  the  role  of  STIM1L  during  thapsigargin  (Tg)­
  induced SOCE, we overexpressed STIM1L in STIM1S­silenced 
myoblasts. Cells were cotransfected with a plasmid encoding 
for the ORF of STIM1L and an siRNA targeting 3 untrans­
lated noncoding sequences of STIM1 mRNA (siSTIM1u). 2 d 
after transfection, Ca
2+ handling was assessed using the fluor­
escent Ca
2+ indicator Fura­2. As shown in Fig. 3 A, STIM1S 
silencing decreased the amplitude of SOCE evoked by readdi­
tion of 1.8 mM Ca
2+ after depletion of the Ca
2+ stores with   
1 µM Tg (red curve). Overexpression of STIM1L in STIM1S­
silenced myoblasts more than compensated for the depletion 
of STIM1S and caused a 312 ± 20% increase of the Tg­ 
induced SOCE when compared with control myoblasts (Fig. 3 A, 
green curve vs. red curve). Western blots were performed on 
extracts obtained from the cells used for Fura­2 measurements 
to correlate as accurately as possible the protein levels with 
the Ca
2+ influxes shown in Fig. 3 A (Fig. 3 B). As shown, pro­
liferating myoblasts only express STIM1S, and STIM1S is si­
lenced by 74 ± 7% (n = 3) 48 h after siSTIM1u transfection. 
As expected, in myoblasts transfected with the STIM1L plas­
mid and siSTIM1u, the 115­kD band was strongly expressed, 
whereas the amount of STIM1S decreased by 70 ± 11% (n = 3). 
From these results, we conclude that STIM1L is able to gen­
erate SOCE independently of the well­characterized SOCE 
partner STIM1S.
The additional sequences present on STIM1L are lo­
cated near regions known to interact with Orai1 (Fig. 2). We 
thus wondered whether Orai1 channels would still be the main 
partner of STIM1L. To test this point, we quantified SOCE in 
Figure 2.  STIM1L alternative splicing. (A) Identification of an alternative 
splicing variant of STIM1 mRNA by RACE. Products of the 3 RACE before 
amplification by nested PCR are shown. 3 RACE of STIM1 mRNA was 
performed in proliferating myoblasts and in myotubes after 120 h of dif-
ferentiation. One band of the expected size of 2.6 kbp was detected in 
myoblasts and myotubes, and an additional band of 2.9 kbp was de-
tected in myotubes (also see Fig. S1 B). (B) Exon/intron map of the human 
3 part of STIM1L. The spliced sequence (red) of STIM1L directly follows 
exon 11 of STIM1S (in silico analysis). UTR, untranslated. (C) A schematic 
of the proteins STIM1S and -L. ABD, actin-binding domain; CAD, Ca
2+ 
release–activated Ca
2+ channel activation domain; CC1, coiled coil 1; 
CC2, coiled coil 2; K, leucine-rich domain; SAM, sterile  motif; SHD, 
STIM  homomerization  domain;  S/P,  serine–proline-rich  domain;  TM, 
transmembrane domain. (D) Amino acid sequence alignment of human 
STIM1S (top sequences) and STIM1L (bottom sequences). Sequences in 
common (exons 11 and 12) are highlighted in green (also see Figs. S1 C   
and S2 [A and B]).JCB • VOLUME 194 • NUMBER 2 • 2011   338
Figure 3.  STIM1L activates Orai1 and is involved in endogenous SOCE. (A, left) Cytoplasmic Ca
2+ was assessed with Fura-2 in proliferating myoblasts 2 d 
after siRNA transfection (siSTIM1u or control siRNA) and 1 d after plasmid electroporation (STIM1L or pcDNA3). As siSTIM1u targets the 3 untranslated 
region of STIM1 mRNA, endogenous STIM1 was silenced, whereas STIM1L vector expression was unaffected. Intracellular Ca
2+ stores were depleted using 
1 µM Tg in a medium containing 250 nM Ca
2+, and, subsequently, 1.8 mM Ca
2+ was added to the external medium to reveal SOCE (traces represent 
the mean ± SEM of 10 cells; one representative experiment out of three that were performed in three different clones). (right) Mean ± SEM peak SOCE 
amplitude out of three experiments. Results were normalized to control peak SOCE. (B, left) STIM1 protein expression. The same myoblasts were used for 
the Western blot shown and for the cytoplasmic Ca
2+ recordings illustrated in A. (right) Mean ± SD of three experiments. Results were normalized to control 
STIM1S expression and corrected for loading differences using -tubulin (-tub). (C) Same protocol as in A, except that STIM1L-YFP was used instead of 
STIM1L vector and EGFPN3 instead of pcDNA3 (control plasmid). Error bars represent mean ± SEM. (D) Orai1 protein expression. The same myoblasts 
were used for the Western blot shown and for the cytoplasmic Ca
2+ recordings illustrated in C. (right) Mean ± SD of three experiments. Results were nor-
malized to control Orai1 expression and corrected for loading differences using -tubulin. Orai1 silencing efficiency was similar in myoblasts expressing 
either EGFPN3 control plasmid or STIM1L-YFP plasmid (not depicted). (E, left) STIM1 expression in myotubes 96 h in differentiation medium and transfected 
with siRNAs (siSTIM1L1, -2, and -3) that target STIM1L-specific sequences. (right) Mean ± SD of STIM1L expression out of three experiments. Results were 
normalized to STIM1L control expression and corrected for loading differences using -tubulin. (F, left) Cytoplasmic Ca
2+ assessed with Fura-2 in myotubes 339 Fast repetitive Ca
2+ signals rely on STIM1L • Darbellay et al.
96 h after siRNA transfection and differentiation induction. SOCE was evaluated as in A. Traces represent the mean ± SEM of three multinucleated myo-
tubes (black and green traces). One representative experiment out of four that were performed in three different clones (15 myotubes were assessed in 
each condition). (right) Mean ± SD peak SOCE amplitudes normalized to control myotubes (n = 4 experiments). (G, left) STIM1 expression in control and 
siSTIM1S-transfected myotubes at 96 h in differentiation medium. (right) Western blot quantifications (mean ± SD of three experiments in three different 
clones). Results were normalized to STIM1L and -S control expression and corrected for loading differences using -tubulin. (H, left) Tg-induced SOCE 
measured with Fura-2 in myotubes at 96 h in differentiation medium and transfected with siSTIM1S or control siRNA (same protocol as in C; mean ± SEM 
of 10 myotubes). (right) Mean ± SD peak SOCE amplitudes out of three experiments. Results were normalized to control SOCE amplitude.
 
To specifically silence STIM1S, we designed and tested 
three siRNAs that overlapped the junction between exon 11 and 
12 of STIM1S mRNA. As this sequence is absent in STIM1L 
mRNA, these siRNAs should silence STIM1S without modify­
ing STIM1L expression. Two siRNAs silenced STIM1S effi­
ciently (73 ± 5 and 66 ± 4% inhibition for siSTIM1S­1 and ­2, 
respectively), whereas one had no effect. STIM1L expression 
was only slightly reduced (17 ± 3 and 19 ± 4% inhibition for 
siSTIM1S­1 and siSTIM1S­2, respectively) by both siRNAs 
that were efficiently silencing STIM1S. Fig. 3 (G and H) illus­
trates the effects of siSTIM1S­1 (the siSTIM1S that was used   
in all subsequent experiments) on STIM1S expression and on Tg­
induced SOCE. SOCE was reduced by 47 ± 12% in STIM1S­
silenced myotubes. Note that, as formerly described, STIM1 
was silenced without impeding differentiation by triggering myo­
blast differentiation immediately after siSTIM1S transfection   
(Darbellay et al., 2009, 2010). As the degree of store depletion 
may determine the amplitude of SOCE, we compared maximum 
amplitude (and also time to peak) of myoplasmic Ca
2+ increases 
upon Tg addition in all conditions described in Fig. 3. No statisti­
cal difference was noted between the various conditions. Lastly, 
being able to specifically silence STIM1S allowed us to con­
firm that endogenous Orai1 is the main partner of endogenous 
STIM1L (Fig. S3 A).
Repetitive Ca
2+ releases rely on the 
immediate activation of the SOCE 
triggered by STIM1L
Experiments described in Fig. 3 (F and H) show that STIM1L 
and  STIM1S  contributions  to  Tg­induced  SOCE  amplitude 
were similar. As muscle cells are known to perform high fre­
quency, high amplitude, and high duration cytosolic Ca
2+ in­
creases relying on release from the internal stores (Miledi et al., 
1977, 1982; Gorassini et al., 2000), we compared the respective 
role of STIM1L and STIM1S during repetitive Ca
2+ releases   
in myotubes. To simulate the excitation/contraction coupling 
mechanism normally occurring during skeletal muscle contrac­
tion, we increased the K
+ concentration of the superfusion 
solution (Stiber et al., 2008; Darbellay et al., 2010). Each extra­
cellular 65­mM KCl pulse generated large cytosolic Ca
2+ tran­
sients that were visualized with Fura­2. Fig. 4 A illustrates that 
control myotubes exposed to seven consecutive pulses of 65 mM 
KCl were able, after an initial decrement, to perform six similar   
cytosolic Ca
2+ peaks. In contrast, STIM1L­silenced myotubes 
were unable to sustain successive Ca
2+ peaks (Fig. 4, B and D). 
After the seven KCl pulses, internal Ca
2+ store content was as­
sessed using 2 µM Tg and 10 mM caffeine in 250 nM of exter­
nal Ca
2+. Compared with control myotubes (Fig. 4 A), Ca
2+ 
store content was reduced by 87 ± 6% in STIM1L­silenced 
myotubes (P < 10
3; Fig. 4 B). Finally, STIM1S silencing inhib­
ited neither KCl­induced Ca
2+ releases nor Ca
2+ store content, 
although the mean Ca
2+ peak in STIM1S­silenced myotubes 
was slightly reduced (Fura­2 ratio was 1.05 ± 0.05 in STIM1S­
silenced myotubes vs. 1.23 ± 0.09 in control myotubes; P < 10
3; 
Fig. 4, C and D). From these results, we concluded that STIM1S­
dependent SOCE is too slow to compensate for the Ca
2+ ex­
trusion occurring during repetitive cytosolic Ca
2+ increases. 
Indeed, in the absence of STIM1L, few releases lasting 15 s 
were sufficient to totally empty internal Ca
2+ stores.
To  test  whether  STIM1L  could  be  responsible  for  a 
rapid SOCE activation that would without delay compensate   
Ca
2+  extrusion,  the  onset  of  SOCE  was  evaluated  by  assess­
ing Mn
2+ quench of Fura­2 (Hoth and Penner, 1992; Fasolato   
et  al.,  1993).  Mn
2+  enters  cells  through  Ca
2+  channels  and 
quenches Fura­2 fluorescence. The decrease of Fura­2 emission 
at 360 nm is thus directly linked to the Ca
2+ influx. Fig. 4 E (top)   
illustrates ER Ca
2+ release triggered by Tg and caffeine in the 
presence of 0.5 mM Mn
2+. Fig. 4 E (bottom) represents, in the 
same cells, Fura­2 quench by Mn
2+ entering through Ca
+2 chan­
nels activated by the ER depletion. As shown, in the presence 
of STIM1L (myotubes), Fura­2 emission at 360 nm strongly 
decreased immediately after Tg and caffeine addition, whereas 
in the absence of STIM1L (myoblasts), a similar decrease   
occurred but was delayed by 2 min. In addition, Ca
2+ influx   
activation was also delayed in STIM1L­silenced myotubes   
(Fig. 4 E, red curve). However, this delay did not occur in 
STIM1S­silenced myotubes (Fig. 4 E, green curve).
The bar graph (Fig. 4 F) illustrates that, in the presence of 
STIM1L (control myotubes), 47 ± 6% of the maximum slope of 
the Fura­2 quench trace was induced immediately after store 
depletion, whereas this fraction dropped to 14 ± 2% in STIM1L­
silenced myotubes (STIM1S present only) and to 11 ± 5% in 
control myoblasts (STIM1S present only). As expected, in 
STIM1S­silenced myotubes (STIM1L present only), the frac­
tion of the maximum slope induced immediately was large   
(83 ± 21%). Fig. S3 B shows that double silencing of STIM1L 
and STIM1S totally inhibited the influx triggered by the Tg and 
caffeine, confirming that this influx was purely STIM1 dependent. 
Results from experiments in which STIM1L is exogenously ex­
pressed in three cell types that do not have endogenous STIM1L 
are in full agreement with the previous findings (shown in Fig. 4, 
E and F). Fig. 4 (G and H) illustrates that exogenous STIM1L­
YFP expression in myoblasts, a human umbilical vein endo­
thelial cell–derived cell line (EA.hy926), and HeLa cells allows 
immediate SOCE activation after Tg. These results have to be 
compared with STIM1S­YFP expression that, in the same cells, 
does not allow immediate SOCE activation. Fluorescence reso­
nance energy transfer (FRET) increase between STIM1S­CFP JCB • VOLUME 194 • NUMBER 2 • 2011   340
observations are directly related to STIM1L properties and not 
to the cell type in which STIM1L is expressed.
The next step was to evaluate whether the STIM1L ad­
ditional sequence is involved in cluster preformation and align­
ment. For that purpose, we cloned the last two exons of STIM1L 
and STIM1S (exons 11 and 12), tagged them with GFP, and 
overexpressed them in myoblasts. Fig. 5 C shows that GFP­
tagged STIM1S exons 11 and 12 were uniformly distributed, 
and neither puncta nor linear structures were ever observed, 
whereas GFP­tagged STIM1L exons 11 and 12 formed linear 
clusters in all observed cells (>100 cells in eight experiments). 
The level of Ca
2+ in stores had no influence on these results, as 
these small constructs lack the Ca
2+ sensor (unpublished data). 
Fig. S4 (A and B) shows that GFP­tagged exons 11 and 12 of 
both STIM1L and STIM1S can be expressed in myoblasts and 
that these fragments have a dominant­negative effect on Tg­ 
induced SOCE amplitude.
As STIM1L forms linear clusters, we assessed a possible 
involvement of actin filaments in the anchoring and permanent 
clustering of STIM1L. Figs. 5 C and S4 C show that STIM1L 
exons 11 and 12–GFP and STIM1L­GFP formed linear clusters 
that perfectly colocalized with actin filaments in unstimulated 
myoblasts. In contrast, STIM1S clusters did not colocalize 
with actin filaments (Fig. 5 D). The distinct patterns of Fig. 5 
(C and D) suggest that STIM1S and STIM1L clusters did not 
colocalize  after  store  depletion.  However,  overexpression  of 
STIM1S­mCherry and STIM1L­GFP in the same cells shows a 
little overlap of STIM1S/L clusters, suggesting that a fraction of 
and ­YFP after stimulation with 2 µM Tg and 10 mM caffeine 
had a t1/2 of 20 ± 3 s (Fig. S3 C), which excludes that the delay 
of SOCE activation in STIM1S­expressing cells was caused by 
a slow action of Tg and caffeine. From these results, we con­
clude  that  fast  SOCE  activation  in  myotubes  depends  on 
STIM1L expression and that fast SOCE activation is required to 
perform repetitive store­dependent Ca
2+ signals.
STIM1L interacts with actin to form 
permanent clusters
The  delay  that  characterized  the  activation  of  the  STIM1S­
dependent SOCE is linked to the process of STIM1S migra­
tion  and  cluster  formation  that  precedes  the  activation  of 
Orai1 channels (Liou et al., 2007). We thus wondered whether 
STIM1L clusters could form faster (or using a different mecha­
nism) than STIM1S clusters. To examine this hypothesis, we 
overexpressed STIM1L­ and STIM1S­YFP into myoblasts and 
compared their cellular distribution before and after Tg­induced 
store depletion. As expected, STIM1S was diffusely distributed 
in resting myoblasts with filled Ca
2+ stores, and clusters formed 
within 2–4 min after Ca
2+ store depletion (Fig. 5 A, left). What 
was not expected, however, was that STIM1L clusters were al­
ready fully formed in resting myoblasts (with filled Ca
2+ stores) 
and that their distribution did not change after Tg exposure   
(Fig. 5 A, right). Interestingly, STIM1L clusters were distributed 
along parallel lines in both conditions. Similar results were ob­
tained with human endothelial cells overexpressing YFP­tagged 
STIM1S or STIM1L (unpublished data), suggesting that these 
Figure  4.  Repetitive  Ca
2+  signals  encoded  by  Ca
2+  release 
rely on STIM1L. (A–C) Ca
2+ transients induced by seven 65-mM 
KCl pulses and evaluated with Fura-2 in control (A), transfected   
siSTIM1L (B), and transfected siSTIM1S (C) myotubes at 96 h in dif-
ferentiation medium. Ca
2+ store content was then assessed using   
2 µM Tg and10 mM caffeine in 250 nM of external Ca
2+ medium. 
Each trace represents the mean of 10 recorded cells. In A and C, 
the horizontal dotted line represents the mean Ca
2+ peak (the first 
peak was excluded), and, in B, the dotted line is an exponential 
fit through Ca
2+ peaks (the first peak was excluded). (D) Ampli-
tude of the second KCl-induced Ca
2+ peak divided by the amplitude 
of the seventh KCl-induced Ca
2+ peak (mean ± SD; 10 cells out 
of four experiments in each condition). (E, top) Cytoplasmic Ca
2+  
assessed  with  Fura-2  in  myoblasts  and  in  myotubes  48  h  after 
transfections with various siSTIM1. Ca
2+ stores were depleted with   
10 mM caffeine and 2 µM Tg in 1.8 mM of external Ca
2+ and   
0.5 mM of external Mn
2+. (bottom) Fura-2 fluorescence at a 360-nm   
excitation.  Cytoplasmic  Ca
2+  and  Fura-2  fluorescence  quench 
were measured simultaneously. No statistical difference was noted   
between maximum amplitude (and also time to peak) of myoplas-
mic Ca
2+ increases upon Tg/caffeine addition. a.u., arbitrary unit.   
(F) Fraction of the maximum slope of Fura-2 quench traces that 
occurred immediately after Ca
2+ store depletion with 2 µM Tg and 
10 mM caffeine. Immediate activation slopes were measured be-
tween times a and b and maximum slopes between times b and c   
in  E.  Mean  ±  SEM  of  six  experiments  using  0.5–1  mM  Mn
2+ 
(13 cells were recorded in each experiment; also see Fig. S3 B).   
(G and H) Fura-2 fluorescence quench at 360 nm measured in myo-
blasts, HeLa cells, and EA.hy926 (human endothelial) cells with 1 mM 
Mn
2+ in the external medium. For HeLa and EA.hy926 cells, Ca
2+ 
stores were depleted with 2 µM Tg in 1.8 mM of external Ca
2+. The 
squares represent the mean of six to eight cells out of three to four   
experiments. The thin lines represent individual cell traces. n.s., not   
significant. The vertical and horizontal dashed lines represent the   
application of Tg (±caffeine) at time 0 and initial Fura-2 fluores-
cence at 360 nm, respectively.341 Fast repetitive Ca
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STIM1L proteins was immunoprecipitated by actin (P = 0.009), 
whereas only 6 ± 4% of endogenous STIM1S was detected. 
Altogether, these results strongly suggest that actin fibers are 
involved in STIM1L cluster preformation in store­filled cells 
through a very close interaction between STIM1L and actin.
Actin fiber disruption dissociates  
STIM1L–Orai1 preformed complexes  
and delays SOCE activation
We first verified that STIM1L clusters (present when Ca
2+ stores 
are filled) colocalized with Orai1 clusters, as this partner is required 
for SOCE activation. To assess this point, we simultaneously over­
expressed Orai1­RFP and STIM1L­YFP in myoblasts. Fig. 6 A  
illustrates that Orai1 forms linear clusters in resting cells and that 
these clusters colocalize with STIM1L clusters. Fig. 6 A also shows 
that, as expected, linear clusters of STIM1L and Orai1 colocalize 
with actin fibers (detected with phalloidin–Atto 390). On the other 
hand, Fig. S5 B illustrates that neither Orai1­RFP nor STIM1S­
GFP formed clusters in myoblasts with filled Ca
2+ stores. FRET 
measurements between STIM1L­GFP and Orai1­RFP confirm that 
STIM1S may be recruited in STIM1L clusters after store deple­
tion (unpublished data). Treatment with 1 µM cytochalasin D   
(3 h at room temperature) largely disrupted the actin organi­
zation in 60% of the myoblasts, and, in these cells, the linear 
organization of STIM1L exons 11 and 12–GFP disappeared, al­
though STIM1L exons 11 and 12–GFP and disrupted fragments 
of actin still colocalized perfectly (Fig. 5 E). A similar result was 
obtained in STIM1L­expressing cells using either 1 µM cytocha­
lasin D or 1 µM latrunculin B, and a partial effect was obtained 
using 0.1 and 0.5 µM cytochalasin D (Figs. S4 C and S5 A). We 
also verified that STIM1S clusters still formed and remained 
stable  in  actin­disrupted  cells  after Tg­induced  Ca
2+  store 
depletion (unpublished data). As shown in Fig. 5 F, endogenous 
STIM1L also forms linear clusters that colocalize with actin in 
STIM1S­silenced myotubes. In addition, Fig. 5 G shows that 
FRET occurs between phalloidin­TRITC–labeled actin and 
STIM1L­GFP, further suggesting a close vicinity (within 10 nm)   
between these two molecules. Finally, Fig. 5 H shows the   
coimmunoprecipitation of STIM1L but not STIM1S using an 
actin antibody. 87 ± 6% of the input amount of endogenous 
Figure  5.  STIM1L  interacts  with  actin  and 
forms permanent clusters that colocalize with 
Orai1  in  store-filled  cells.  (A)  Distribution  of 
STIM1S-YFP and STIM1L-YFP overexpressed in 
myoblasts before and after treatment with 2 µM 
Tg. The bar graph represents the total surface 
area of clusters in the various conditions. Clus-
ters were detected with an automatic detection 
of fluorescence intensity variations called “by 
edges” (mean ± SD and n = 5 experiments; 
MetaMorph  7.5.6;  Molecular  Devices).  Bar, 
20 µm. (B) Distribution of STIM1S exons 11 
and 12–GFP and STIM1L exons 11 and 12–
GFP in store-emptied cells using 2 µM Tg. Red 
rectangles show enlarged images. Bar, 20 µm. 
(C–E) Distribution and colocalization of actin 
(detected  by  phalloidin-TRITC)  and  STIM1L   
exons 11 and 12–GFP (C), distribution of actin 
(detected  by  phalloidin-TRITC)  and  STIM1S-
YFP 5 min after treatment with 2 µM Tg (D), 
and distribution of actin (detected by phalloi-
din-TRITC) and STIM1L exons 11 and 12–GFP 
in myoblasts treated with 1 µM cytochalasin D 
for 3 h at room temperature (E). Bars, 20 µm.   
(F) Distribution of endogenous STIM1L (detected 
with an antibody against both STIM1 isoforms) 
and actin (detected by phalloidin–Atto 390) 
in  STIM1S-silenced  myotubes.  Bar,  5  µm.   
(B–F) One representative cell out of >40 cells in 
three experiments. (G) Acceptor photobleach-
ing  method  to  measure  FRET  between  actin 
(detected  by  phalloidin-TRITC)  and  STIM1L-
GFP in fixed myoblasts 24 h after electropora-
tion. The blue and red circles indicate regions 
used for GFP fluorescence measurements, and 
white squares indicate 561-nm bleached re-
gions. The bar graph illustrates the mean ± SD 
of GFP fluorescence increases when acceptor 
(actin-phalloidin-TRITC) is bleached. Measure-
ments  were  normalized  to  GFP  fluorescence 
variation in control regions (fluorescence ratio 
of red regions [2:1] was divided by the fluores-
cence ratio of blue regions [2:1]). Bar, 10 µm.   
(H)  Western  blot  illustrating  coimmunopre-
cipitation (IP) of endogenous STIM1L using an 
antibody  against  actin.  One  representative 
experiment out of three. All images are shown 
in pseudocolors.JCB • VOLUME 194 • NUMBER 2 • 2011   342
SOCE activation conferred by STIM1L overexpression in myo­
blasts (Fig. 4 G) was reversed by actin disruption (Fig. 6 E).   
Fig. 6 F shows the distribution in myoblasts of STIM1L­589–599­
GFP, a mutant missing an amino acid sequence located within the   
actin­binding domain. Neither clusters nor lines were observed in 
store­filled myoblasts transfected with this mutant. Fig. 6 F also 
shows that, although store depletion with Tg still induced cluster   
formation, these clusters did not colocalize with actin fibers. Lastly, 
Fig. 6 G illustrates that Mn
2+ quench of the Fura­2 fluorescence 
was severely delayed in STIM1S­silenced myoblasts expressing 
STIM1L­589–599­GFP, an expected result in the absence of per­
manent STIM1L clusters in store­filled cells. From these results, 
we conclude that actin fibers stabilize inactivated STIM1L–Orai1 
complexes in naive store­filled cells and, by this mechanism,   
allow fast SOCE activation upon Ca
2+ store depletion in STIM1L­
expressing cells.
these two molecules are located in close proximity (Fig. 6 B, left 
images and right blue bars) and that this close proximity is dis­
rupted by 1 µM cytochalasin D ( Fig. 6 B, red bars). The absence of 
FRET between STIM1S­GFP and Orai1­RFP in store­filled myo­
blasts was assessed as a control (Fig. 6 B, green bars).
Finally, we assessed the impact on SOCE of actin disrup­
tion and transfection of an STIM1L mutant missing amino acids 
589–599 (STIM1L­589–599­GFP), a mutant that did not form 
permanent clusters in store­filled cells. Fig. 6 C shows that actin 
disruption with 1 µM cytochalasin D had no effect on endogenous 
maximal SOCE amplitude in normal or STIMS­silenced myo­
tubes. This result suggests that neither STIM1L nor STIM1S relies 
on actin integrity to control maximal SOCE amplitude. However, 
and as expected, endogenous SOCE activation was clearly de­
layed in myotubes after actin depolymerization with 1 and 0.5 µM   
cytochalasin  D  (Fig.  6  D). Accordingly,  the  acceleration  of 
Figure 6.  Actin fiber disruption dissociates STIM1L–
Orai1 preformed complexes and delays SOCE activa-
tion. (A) Distribution and colocalization of STIM1L-GFP, 
Orai1-RFP, and actin in resting myoblasts (filled Ca
2+ 
stores). Actin was detected with phalloidin–Atto 390. 
One representative cell out of >30 cells in three experi-
ments. The red box outlines the enlarged image shown 
on the bottom. Bar, 5 µm. (B) Acceptor photobleach-
ing method to measure FRET between Orai1-RFP and 
either STIM1L- or STIM1S-GFP in fixed myoblasts 24 h   
after electroporation. The bar graph shows the mean ± 
SD,  and  the  horizontal  dashed  line  represents  the 
control FRET level. GFP fluorescence increases when 
acceptor  (Orai1-GFP)  is  bleached  (n  =  8  for  each 
condition). Analysis was performed as described in 
Fig. 5 G. The blue and red circles indicate regions 
used for GFP fluorescence measurements, and white 
squares indicate 561-nm bleached regions. Bar, 5 µm.   
(C) Cytoplasmic Ca
2+ assessed with Fura-2 to evaluate 
maximum SOCE in control and STIM1S-silenced myo-
tubes in the absence or presence of 1 µM cytochalasin D.   
Ca
2+  stores  were  depleted  with  2  µM  Tg  and   
10 mM caffeine in 250 nM of external Ca
2+, and, sub-
sequently, 1.8 mM Ca
2+ was added to the external 
medium to reveal SOCE (traces represent the mean ± 
SEM of 76 cells; n = 3 experiments in three clones). 
(D) Fura-2 fluorescence quench at 360 nm measured in   
myotubes (with 1 mM Mn
2+ in the external medium) in   
the absence or presence of 0.5 and 1 µM cytochala-
sin D. Ca
2+ stores were depleted with 2 µM Tg and   
10 mM caffeine in 1.8 mM of external Ca
2+ (mean ± SEM   
of 16 cells; n = 3 experiments). (E) Same experiment 
as in D, except that myoblasts overexpressing STIM1L-
YFP and Orai1-RFP were used instead of myotubes 
and that actin depolymerization was obtained using   
1 µM latrunculin instead of cytochalasin D (mean ± SEM 
of 13 cells; n = 3 experiments). (F) Myoblasts at 24 h 
after electroporation with STIM1L-589–599-GFP be-
fore and after treatment with 2 µM Tg for 15 min (one 
representative  experiment  out  of  three).  Bar,  5  µm.   
(G) Fura-2 fluorescence quench at 360 nm measured 
in  STIM1S-silenced  myoblasts  (with  1  mM  Mn
2+  in 
the external medium and 48 h after siSTIM1S trans-
fection)  expressing  either  STIM1L-589–599-GFP   
or STIM1L-GFP. Ca
2+ stores were depleted with 2 µM   
Tg and 10 mM caffeine in 1.8 mM of external Ca
2+ 
(mean  ±  SEM  of  12  cells;  n  =  5  experiments).   
(D, E, and G) Vertical dashed lines represent the application of Tg and caffeine at time 0, and horizontal dashed lines represent the initial Fura-2 fluorescence at 
360 nm. (H) SOCE activation by STIM1L and -S. In resting (store filled) cells, STIM1L is already associated with Orai1 and forms permanent clusters via its 
interaction with actin filaments. Upon store depletion, STIM1L triggers SOCE without delay. STIM1S-dependent SOCE requires homomerization, migration, 
and cluster formation of STIM1S molecules, a process that needs 2 min to take place. This second process, which occurs during a long-lasting decrease 
of the Ca
2+ store content, results in a global increase of SOCE amplitude. All images are shown in pseudocolors. ABD, actin-binding domain of STIM1L; 
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STIM1S­related SOCE rapidly emptied the Ca
2+ content of the 
stores. Physiological muscle contractions involve repetitive 
bursts of tetanic stimulations that may last a few seconds (Miledi   
et al., 1977, 1982; Buchthal and Schmalbruch, 1980; Stein   
et al., 1988; Kiehn and Eken, 1997, 1998; Gorassini et al., 2000; 
Rekling et al., 2000). As cytosolic Ca
2+ concentration remains 
elevated during most of the tetanic contraction, such a stimula­
tion pattern produces a small but constant extrusion of Ca
2+  
in the extracellular space through the plasma membrane Ca
2+ 
ATPase and Na
+­Ca
2+ exchanger (Cifuentes et al., 2000; Caride 
et al., 2001). To compensate for this Ca
2+ efflux, SOCE or other 
Ca
2+ influxes need to be activated as soon as contraction begins. 
We thus propose that STIM1L may be involved in the rapid 
SOCE activation required to compensate for the Ca
2+ efflux   
occurring during normal muscle contraction (Stiber et al., 2008). 
This model would explain well why skeletal muscle contraction 
requires functional SOCE (Kurebayashi and Ogawa, 2001; 
Zhao et al., 2005; Ducret et al., 2006; Lyfenko and Dirksen, 
2008; Stiber et al., 2008; Dirksen, 2009; Darbellay et al., 2010; 
Edwards et al., 2010; Launikonis et al., 2010), even though 
SOCE amplitude would appear, a priori, as insufficient to sig­
nificantly contribute to Ca
2+ store refilling when compared with 
Ca
2+ recycling by the sarco/ER Ca
2+ ATPase. It would further 
explain why, in Stim1
+/ knockout mice, muscle weakness is 
only revealed during tetanic stimulations, whereas single­twitch 
contractions are normal (Stiber et al., 2008).
Based on the findings in the present and former studies 
(Miledi et al., 1982; Launikonis and Ríos, 2007; Stiber et al., 
2008; Feske, 2009; Launikonis et al., 2009; McCarl et al., 2009; 
Darbellay et al., 2010; Edwards et al., 2010), we propose the 
model summarized in Fig. 6. The presence of a new STIM iso­
form, STIM1L, able to permanently cluster STIM1 molecules 
and  thus  activate  SOCE  immediately  after  store  depletion, 
would allow any cell type to perform repetitive cytosolic Ca
2+ 
releases with frequencies in seconds or faster.
Materials and methods
Cell culture
Muscle samples, cell dissociation, and clonal culture from satellite cells 
were prepared as previously described (Baroffio et al., 1993; Arnaudeau 
et al., 2006). In brief, muscle biopsies were minced and incubated for 1 h 
in a solution containing 0.5 mg/ml
1 trypsin. The suspension was centri-
fuged and resuspended several times in a wash medium to remove muscu-
lar debris (Ham’s F10 with 15% FCS). Red blood cells were lysed with 
Tris–ammonium chloride buffer. Using a micropipette, single satellite cells 
were then manually collected (clonal culture). Human muscle samples were 
obtained from eight children (operated for clubfoot and <4 yr old) without 
any known neuromuscular disease. Plasmids (Orai1-RFP was provided by 
D. Al-Ansary and B. Niemeyer, Saarland University, Homburg, Germany; 
STIM1-YFP [19754; Addgene; Prakriya et al., 2006], STIM1S-mCherry, 
STIM1L, STIM1L-YFP, STIM1S–C terminal, and STIM1L–C terminal) were 
transfected by electroporation with a Nucleofector II device (Lonza). Fol-
lowing the manufacturer’s protocol, a suspension of 5 × 10
5 myoblasts, 
HeLa cells, or endothelial cells (provided by C.J.S. Edgell, University of 
North Carolina at Chapel Hill, Chapel Hill, NC) and 2 µg plasmid DNA 
and/or 0.1–0.2 nM siRNA was electroporated. The transfection efficiency 
assessed by FACS was >80% for tagged plasmids.
siRNA knockdown
Myoblasts  were  transfected  in  suspension  by  incubating  4  ×  10
5 
cells  in  a  solution  containing  500  µl  Opti-MEM,  3  µl  Lipofectamine 
RNAiMax (Invitrogen), and 20 pmol of a specific siRNA (Invitrogen)   
Discussion
Here,  we  identified  a  longer  form  of  the  STIM1  protein, 
STIM1L, which allows immediate activation of SOCE and is 
required to trigger repetitive cytosolic Ca
2+ releases. STIM1L is 
the product of an alternative splicing on exon 11 of the STIM1 
gene and is expressed in many mammalian tissues. Live cell im­
aging showed that STIM1L–Orai1 clusters were already present 
at rest when Ca
2+ stores were full. In contrast, STIM1S mole­
cules were diffusely distributed at rest, and it took >1 min for 
STIM1S clusters to fully form after Ca
2+ store depletion (Liou 
et al., 2007). As the main cause of the STIM1S­related SOCE 
activation delay appears to be the time required for STIM1S 
to migrate, form clusters, and bind to Orai1 (Liou et al., 2007;   
Navarro­Borelly et al., 2008; Calloway et al., 2009), the presence 
of permanent STIM1L–Orai1 clusters could explain the rapid 
SOCE  activation  in  STIM1L­expressing  cells.  In  myoblasts, 
STIM1S oligomerized within 10 s of Tg and caffeine applica­
tion (Fig. S3 C), whereas SOCE activation was delayed >1 min 
(Fig. 4 G). A similar result was obtained in myotubes. These ob­
servations confirm that the delay characterizing STIM1S­related 
SOCE activation is a result of the overall process of STIM1S 
oligomerization, migration, and binding to Orai1. The kinetics 
of STIM1S oligomerization after store depletion (<10 s; Fig. S3 C) 
also suggests that a difference between STIM1S and STIM1L 
luminal Ca
2+ affinity, if present, will not play a major role in the 
overall delay of STIM1S­dependent SOCE activation. Here, we 
also showed that the formation of permanent clusters is directly 
linked to the interaction of the added sequence of STIM1L with 
actin, as STIM1L­GFP, the GFP­tagged exons 11 and 12 of 
STIM1L, and endogenous STIM1L form linear clusters that co­
localize with actin and disappear upon actin depolymerization. 
In addition, endogenous STIM1L was coimmunoprecipitated 
by actin. Finally, we observed that an STIM1L mutant missing a 
10–amino acid sequence within the actin­binding domain forms 
clusters only after store depletion, does not colocalize with 
actin, and triggers slow SOCE activation. Although these last   
results do not prove a direct binding between the 589–599 amino 
acid fragment and actin, they clearly suggest that this fragment 
is required for the STIM1L–actin interaction to take place.
In skeletal muscle fibers, SOCE has been shown to be 
maximally activated in <1 s after the initiation of the Ca
2+ store 
release, whereas full SOCE activation takes several seconds (up 
to 260 s for complete cluster formation) in other cell types 
(Parekh and Putney, 2005; Wu et al., 2006; Launikonis and 
Ríos, 2007; Liou et al., 2007; Navarro­Borelly et al., 2008;   
Calloway et al., 2009). We confirmed that, in human myotubes, 
the immediate activation of SOCE relies on endogenous STIM1L 
and that exogenous expression of STIM1L triggers immediate 
SOCE activation regardless of the cell types, linking this spe­
cific feature of SOCE to STIM1L expression. As actin depoly­
merization disrupts STIM1L–Orai1 resting complexes and delays 
SOCE activation without decreasing maximal SOCE amplitude, 
we conclude that STIM1L–actin interaction stabilizes preformed 
SOCE complexes, which in turn trigger fast SOCE activation.
In  STIM1L­silenced  myotubes,  repetitive  Ca
2+  release 
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Ratios of transfected plasmids (GFP/RFP) were 1:2. Wavelengths of the   
excitation laser beam were 488 and 561 nm. Images were acquired and 
analyzed using Nikon software.
Cloning
Total RNA from 2 × 10
6 myoblasts was extracted using TRIZOL reagent   
(Invitrogen). In brief, chloroform was added to the TRIZOL, extracts were cen-
trifugated to eliminate the phenol-chloroform solution, and the aqueous 
part was purified. Isopropanol was then added to the aqueous part to pre-
cipitate RNA. Precipitates were washed with 75% ethanol and finally re-
suspended in 20 µl diethylpyrocarbonate water. RACE was performed on 
5 µg of total RNA (Gene Racer kit; Invitrogen). In brief, after RNA dephos-
phorylation, decapping, and 5 oligonucleotide ligation, reverse transcrip-
tion  was  performed  using  200  U  Superscript  III  reverse  transcriptase 
(Invitrogen) according to the manufacturer’s protocol. We amplified by 
PCR the cDNA ends using Platinum Taq DNA Polymerase (Invitrogen) and 
the following primer couples: 5 ends, GeneRacer 5 and exon 9 reverse 
5-GGAAGGTGCCAAAGAGTGTG-3, and 3 ends, GeneRacer 3, and 
exon 6 forward 5-CATGCTGGTGGTGTCTATCG-3.
Products were further amplified by nested PCR using exon 7 re-
verse  5-TCCGCTCATTCTCAGTACCC-3  and  exon  7  forward  5-GCGG-
GAGGGTACTGAGAATG-3 for amplification of 5 RACE and 3 RACE 
products, respectively. The different PCR products obtained were cloned in 
the TOPO TA cloning kit (Invitrogen) for sequencing.
We cloned both full-length STIM1S and -L cDNA by PCR on reverse-
transcribed  mRNA  from  myotubes  using  the  following  primer  couples: 
STIM1-533F,  5-TCCACATCAGACGCATGTTG-3,  and  STIM1-2713R,   
5-GGCCAGTTATCTTGAAGGAAGG-3.  Expression  vectors  encoding 
STIM1S and -L were obtained by cloning the full-length PCR products into 
the pcDNA 3.3-TOPO TA vector using the pcDNA 3.3-TOPO TA cloning kit 
according  to  the  manufacturer’s  protocol  and  sequenced.  The  115-kD 
STIM1 isoform tagged with YFP and YFP-STIM1L was obtained by cloning 
the Pml1–Bgl2 fragment from pcDNA-STIM1L into Pml1–BamH1 sites of the 
SP-YFP-STIM1 plasmid (plasmid 19754; Addgene).
DNA corresponding to exons 11 and 12 from both STIM1S and -L 
were  amplified  by  PCR  (exon  11,  Xho1  forward  5-TTTTCTCGAGC-
TTCCCCTAGCCTGCAGAG-3, and exon 12, BamH1 reverse 5-GAGA-
GGATCCATCCTGCCTACTTCTTAAGAG-3)  and  inserted  into  Xho1–BamH1 
sites from pEGFP-C1 (BD) to obtain the plasmids GFP-tagged STIM1L or -S 
C terminus (GFP-STIM1L–C terminal and GFP-STIM1S–C terminal). Exon 11 
of STIM1S and -L starts at serine 492. For STIM1S, exon 12 ends at leucine 
685 and, for STIM1L, at leucine 791.
Statistics
A Student‘s t test was used where p-values are indicated. Error bars repre-
sent SD in Western blot quantification and SEM in Fura-2 experiments. To 
confirm the results obtained with siSTIM1L1 and siSTIM1S1, each experi-
ment was repeated at least three times with a second siRNA for STIM1S 
and, for STIM1L, with two additional siRNAs. No significant differences 
were noted between the effects of the different siRNAs.
Online supplemental material
Fig. S1 shows STIM1L identification by Western blotting and RACE and 
the  nucleotide  sequence  of  the  spliced  exon.  Fig.  S2  shows  sequence 
alignment of the putative alternative splicing domain of STIM1L in several 
species and confirmation of the presence of two STIM1 mRNAs in myo-
tubes by RT-PCR. Fig. S3 shows Tg-induced SOCE when both STIM1S and 
Orai1 are silenced in myotubes, Fura-2 fluorescence quench after store 
depletion when both STIM1S and STIM1L are silenced in myotubes, and 
STIM1S activation measured by FRET after store depletion. Fig. S4 shows 
expression of YFP-tagged exons 11 and 12 of STIM1S and -L in myo-
blasts assessed by Western blotting, Tg-induced SOCE in myoblasts ex-
pressing YFP-tagged exons 11 and 12 of STIM1S and -L, and distribution 
of YFP-STIM1L before and after actin depolymerization with cytochalasin   
D. Fig. S5 shows the effects of cytochalasin D and latrunculin on STIM1L 
distribution and the distribution of STIM1S-GFP and Orai1-RFP in store-filled 
myoblasts. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201012157/DC1.
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according  to  manufacturer  protocols  (Invitrogen).  The  transfection  effi-
ciency assessed by Alexa Fluor red fluorescent oligonucleotide (Block-iT;   
Invitrogen)  measurements  was  90%.  Three  different  siSTIM1  siRNAs 
(Invitrogen)  targeting  the  longer  STIM1  isoform  (STIM1L)  were  used 
(sense strand siRNA): siSTIM1L-1 5-GCCGGGUAUCUCUGCGGCGtt-3,   
siSTIM1L-2  5-UGCGCAGCCUUUCAUCUGGtt-3,  and  siSTIM1L-3 
5-GGCUACGGGACCAGCUCUCtt-3.
These different siRNAs gave similar results on protein amount silenc-
ing analyzed by Western blots. To simplify, all results shown in this study 
were obtained with siSTIM1L-1. STIM1 and Orai1 siRNAs were previously 
described  as  siSTIM1a  (siSTIM1  in  this  study),  siSTIM1b  (targeting  the   
3 untranslated noncoding region of the STIM1 mRNA and called siSTIM1u in 
this study), and siOrai1b (Darbellay et al., 2009). Two different siSTIM1 
siRNAs (Invitrogen) targeting the shorter STIM1 isoform (STIM1S) were 
used  (sense  strand  siRNA):  siSTIM1S-1  5-GGGAUCUCAGAGGGAU-
UUGtt-3 and siSTIM1S-2 5-CAGAGGGAUUUGACCCAUUtt-3.
siSTIM1S-1 and siSTIM1S-2 give similar results on STIM1S amount 
on Western blots. To simplify, all results shown in this study were obtained 
with siSTIM1S-1. The siRNA siMed negative control (Invitrogen) was used 
as a control.
Western blots and immunoprecipitations
Western  blots  were  performed  as  previously  described  (Konig  et  al., 
2004).  In  brief,  myoblasts  were  lysed  using  NP-40  extraction  buffer   
(Invitrogen). Total proteins were separated on an SDS-PAGE and transferred to 
nitrocellulose  membranes.  Membranes  were  incubated  in  T-TBS  (0.1% 
Tween 20, 20 mM Tris-HCl, pH 7.5, and 137 mM NaCl) and 5% nonfat 
milk. Blots were incubated overnight with the following primary antibodies 
diluted in T-TBS and nonfat milk: mouse monoclonal antibody anti-GOK/
STIM1 (1:500; BD), rabbit antibodies anti-STIM1 (1:2,000, N and C ter-
minal; Sigma-Aldrich), rabbit polyclonal anti-Orai1 (1:1,000; Prosci), 
mouse  monoclonal  antibody  anti–-tubulin  (1:10,000,  clone  DM1A; 
Sigma-Aldrich), and mouse monoclonal antiactin (1:50,000, clone C4; 
Millipore). Blots were incubated for 1 h with HRP-conjugated goat anti–
mouse or –rabbit diluted antibodies (1:6,000; Bio-Rad Laboratories). Anti-
bodies were revealed using Plus-ECL reagents (PerkinElmer) and Hyperfilm 
ECL (GE Healthcare). Optiquant 03.00 software (Packard Instrument Com-
pany) was used to quantify the level of protein expression. -Tubulin is 
shown as a loading control. Protein extracts from severe combined immuno-
deficiency mice were used to assess STIM1 expression in various organs.   
Actin immunoprecipitation was performed using approximately two million 
differentiated myoblasts in NP-40 buffer. Samples were precleared with 
protein G beads. Cells were incubated overnight with antiactin antibody 
and protein G beads. Precipitate was then washed with buffer before   
performing  the  Western  blots.  T  cells  were  provided  by  J.M.R.  Garriz   
(Geneva University Hospital, Geneva, Switzerland).
Cytosolic calcium measurements and fluorescence imaging
Myoblasts grown on coverslips were loaded 30 min at room temperature 
with  the  cell-permeant  fluorescent  Ca
2+  indicator  Fura-2–acetoxymethyl 
(AM; Biotium, Inc.). Fura-2–AM preparation was performed as previously 
described (Arnaudeau et al., 2006). In brief, Fura-2–AM was diluted in 
medium to a final concentration of 2 µM from a DMSO stock solution 
containing  1  mM  Fura-2–AM,  100  mg/ml  Pluronic  F127  (Invitrogen), 
and 0.1% acetic acid. Ratiometric images of Fura-2 fluorescence were 
monitored using an Axiovert microscope (S100 TV; Carl Zeiss) equipped 
with a monochromator (Optoscan; Cairn Research Limited), which rapidly 
changed the excitation wavelengths between 340 and 380 nm. Fluores-
cence emissions were captured through a filter (510WB40; Omega Op-
tical, Inc.) using a digital camera (CoolSnap HQ; Photometrics). Image 
acquisition and ratio analysis were performed using Metafluor software 
(6.3r7; Molecular Devices). The maximal ratio was evaluated in all condi-
tions (using a solution containing 4 µM ionomycin and 5 mM Ca
2+), ruling 
out any possible nonlinearity between data obtained in myoblasts trans-
fected with different plasmids or siRNA. No significant difference between 
the various maximal ratios was found. No significant differences between 
the level of expression of YFP, GFP, and RFP fluorescence intensities were 
noted. As tags were fused to STIMs or Orai, discrepancies between the lev-
els of expression of the proteins were excluded. Actin was detected using 
phalloidin-TRITC (Millipore) and phalloidin–Atto 390 (Sigma-Aldrich).
Confocal FRET measurements
Confocal image acquisition of FRET between STIM1L-GFP (or STIM1S-GFP) 
and Orai1-RFP (or phalloidin-TRITC; Millipore) was performed on fixed 
cells using a confocal microscope (Eclipse Ti-A1r; Nikon) with a 100× Plan 
Apochromat violet-corrected 1.4 NA with a working distance of 0.13 mm. 345 Fast repetitive Ca
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